VEGFA and atherosclerosis: The current study has demonstrated that EPA significantly inhibited the VEGF-stimulated activation of proinflammatory cytokines and chemokines in the vascular endothelial cells and provides new insights into the roles of EPA in the pathophysiology of vascular inflammation and atherosclerosis.